Skip to content
PulseMS
Back to feed
AI CuratorAI-generated
Research summary ·
AI summary · not yet reviewedSubjects not reportedNot reportedPeer review unconfirmed

T-cell Chemokine Receptor Expression in Relapsing-Remitting MS Models with Vitamin D and Curcumin

In a study involving patients with relapsing forms of multiple sclerosis (MS), those in relapse displayed higher levels of specific T cells compared to healthy controls. Following treatment with vitamin D and curcumin, these T cell levels normalized. The treatment also reduced the overall density of certain T cell receptors in relapse patients and showed differential effects on T cells connected to inflammation during relapse.

Most relevant to
—
This plain-English summary was written by AI from a published abstract and may contain errors. It is not medical advice. Read the original study and talk to your MS team before making decisions about treatment.

Why it matters

Understanding the impact of vitamin D and curcumin on T cell receptor expression is crucial as it may reveal potential immunomodulatory mechanisms that could influence relapse rates in MS. The normalization of certain T cell types suggests a promising approach to manage inflammation.

What this does not prove

The precise combined effects of vitamin D and curcumin on T-cell chemokine receptor expression in MS are still not well defined, indicating that more comprehensive studies are needed.

Next milestone

No next milestone was established from the available source.

Study facts
Study design
Not reported
Participants / samples
Not reported
Randomised
Not reported
Controlled
Not reported
Primary endpoint met
Not reported
Relevant MS type
RRMS
Publication date
2026-08-12
Evidence reviewed
Abstract only
Regulatory approval
Not reported
Research areas
Not classified

Original sources

Supporting passages (7)
sample size basisPeripheral blood mononuclear cells were collected from patients in relapse (n=10), remission (n=14), and healthy controls (n=15) and analyzed using flow cytometry.
relevant ms typesRRMS
publication date2026-08-12
interventionVitamin D and Curcumin
primary endpointT-cell chemokine receptor expression
findingsRelapse patients exhibited elevated frequencies of CXCR3+CD4+ T cells compared to healthy controls, which normalized following treatment.
limitationsVitamin D and curcumin are known to possess anti-inflammatory and immunomodulatory properties; however, their combined effects on T-cell chemokine receptor expression in MS remain poorly defined.

AI assessment, not yet reviewed by a person · version 1 · Community votes are separate from evidence review.

0

Discussion 0 comments

Log in or join to comment.